Three small cohort studies 148,149,150 examined associations between GLP-1RA use and metabolic changes in adults with a diagnosis of schizophrenia and comorbid diabetes and/or obesity on antipsychotics
Morning GLP-1 injections: the case for early dosing Morning injections have become the most popular choice among GLP-1 users, and for good reason
Ro offers the following FDA-approved GLP-1 medications: Wegovy (semaglutide): available as a pen and pill (both have cash-pay options) Foundayo (orforglipron): available as a pill (has a cash-pay option) Zepbound (tirzepatide): available as a pen or KwikPens and vials (the latter two have cash-pay options) Ozempic (semaglutide): available as a pen GLP-1s mimic a natural hormone in the body known as glucagon-like peptide-1 (GLP-1)
It May Have Fewer Side Effects The most common side effects of GLP-1 drugs are gastrointestinal issues such as nausea, diarrhea, vomiting and constipation
For individuals with severe or complex obesity (higher BMI and significant health issues), bariatric surgery is often considered the more effective and durable treatment, especially for long-term weight maintenance and disease remission
When combined with a personalized weight management plan , GLP-1 therapies can lead to significant and sustainable weight loss
